Why Delayed Lab Results Are Holding Back Advanced Biotech Manufacturing – And How Real-Time Data Can Fix It

Right now, many biotech manufacturers are making important decisions about their production based on lab results that are two hours old. This delay happens because critical measurements—like cell density and nutrient levels—are still mostly taken through manual samples and slow lab tests instead of real-time sensors. While this system worked in the past when biotech processes were simpler, today’s advanced manufacturing requires faster, smarter control systems, such as continuous processing or automated feedback loops. These systems need data that updates almost instantly to work properly. If the data feeding a control system is already outdated, the system can’t respond quickly enough to keep the process running at its best. For example, a feeding system relying on glucose levels from two hours ago isn’t truly controlling anything—it’s just following a schedule with some guesswork mixed in. As a result, manufacturers often play it safe by using more resources than needed, leading to lower cell density, higher costs, and less consistent product quality. The good news is that real-time tools, like process Raman spectroscopy, can continuously monitor multiple critical factors without disrupting production. However, the bigger challenge is making sure the data is reliable and can be seamlessly integrated into automated systems. This is the focus of an upcoming webinar, where experts will discuss how to implement these technologies effectively, share real-world success stories, and explain how to achieve measurable improvements in efficiency and yield. The key takeaway? The future of biotech manufacturing depends on getting accurate data at the right time—not just collecting more data.

Leave a Comment

Scroll to Top